Enzo Biochem, Inc.
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
9
Ending by 2030
Dec 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Dec 6 to 25, 2026 · next Dec 6
- 1 fee due Feb 15, 2027The maintenance fee for Sphingosine Pathway Modulating Compounds for the Treatment of Coronavirus Infection (US 11,723,895) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
- 2 fees due Mar 5 to 15, 2027 · next Mar 5
- 1 fee due Jun 3, 2027The maintenance fee for Diagnosis and Treatment of Viral Diseases (US 10,495,641) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
- 1 fee due Aug 2, 2027The maintenance fee for Autophagy and Phospholipidosis Pathway Assays (US 9,250,249) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
- 1 fee due Sep 19, 2027The maintenance fee for Sphingosine Pathway Modulating Compounds For The Treatment Of Coronavirus Infection (US 11,931,344) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
- 1 fee due Oct 21, 2027The maintenance fee for Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor (US 10,626,170) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Sphingosine Pathway Modulating Compounds for the Treatment of Cancers (US 10,646,459) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 2 terms have ended since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,066,694 | Affinity Tag Nucleic Acid and Protein Compositions, and Processes for Using Same In force · Medium confidence | In force | Medium confidence | |
| US 10,196,672 | Affinity Tag Nucleic Acid and Protein Compositions, and Processes for Using Same In force · Medium confidence | In force | Medium confidence | |
| US 8,097,405 | Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs In force · From the USPTO record | In force | From the USPTO record | |
| US 8,124,334 | Selective Detection of Oncogenic HPV In force · High confidence | In force | High confidence | |
| US 9,932,479 | Novel Dyes and Compositions, and Processes for Using Same in Analysis of Protein Aggregation and Other Applications In force · High confidence | In force | High confidence | |
| US 9,403,882 | Sulfation of WNT Pathway Proteins In force · High confidence | In force | High confidence | |
| US 10,626,170 | Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor In force · High confidence | In force | High confidence | |
| US 10,899,827 | Antibodies Specific for Sulfation Sites of Sclerostin In force · High confidence | In force | High confidence | |
| US 11,667,703 | Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor In force · High confidence | In force | High confidence | |
| US 10,328,120 | Pharmaceutical Compositions Targeting WNT Pathway Proteins In force · High confidence | In force | High confidence |
Also on record, not counted in the 35: 11 patents in force now held by others · 2 lapsed for an unpaid fee · 60 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 28 abandoned · 1 no status recorded